Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...
It is the memory-robbing disease that people fear the most as they age - and it is even more tragic when it strikes early.
With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, the European Union, and China. This milestone reinforces Vyluma’s vision of ...
In this Healio Video Perspective from Retina 2025, Ramiro Ribeiro, MD, PhD, of EyePoint Pharmaceuticals, discusses Duravyu, a vorolanib intravitreal insert. According to Ribeiro, in the DAVIO 2 trial, ...
Nicotinamide therapy for glaucoma should be used only with careful liver monitoring, according to guidelines from 2 ...